Leaderboard
Anzeige
medline.ch
En
|
De
Impressum
No articles selected!
View Cart
You are here:
Urology-Nephrology
»
Neoplasia/BPH
10. July 2025
Search
medline.ch
Neoplasia/BPH
Advanced search
Dermatology
Endocrinology
Nutrition
Gastroenterology
Gynecology
Haematology
Infectious diseases
Cardiovascular Diseases
Musculoskeletal Diseases
Neurology
Oncology
ORL
Pediatrics
Psychiatry
Respiratory Tract
Sports
Urology-Nephrology
Inflammation-Infection
Nephrolithiasis
Renal Failure
Sexuality
Neoplasia/BPH
Others
Rect Top
Anzeige
Zoom:
Page 1 of 8893
Articles 1 - 20 / 177845
Letter to the editor; comments on "metabolomic profile and its association with the diagnosis of prostate cancer: a systematic review".
J Cancer Res Clin Oncol
Cheema U, Sultana R, Cheema S, Cheema HI.
PMID: 40632307 [PubMed - in process]
Lessons learned from our preliminary experience with MiLEP: a retrospective analysis of efficacy and safety using slim and ultra-slim instruments.
World J Urol
Rein P, Meisl C, Burkardt O, Abt D.
PMID: 40632277 [PubMed - indexed for MEDLINE]
Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancer.
BJU Int
von Deimling M, Furrer M, Bianchi A, Pichler R, Maas M, Tully KH, Longoni M, Mertens LS, Taylor J, Del Giudice F, Li R, Gallioli A, Albisinni S, Crocetto F, Velev M, Afferi L, Mari A, Laukhtina E, Klemm J, Singla N, Fisch M, Spiess PE, Lotan Y, Moschini M, Black PC, Antonelli A, Kiss B, Shariat SF, Pradere B, CLIPOLY study group collaborators.
PMID: 40631580 [PubMed - as supplied by publisher]
Efficacy of Metastasectomy for Metastatic Bladder Cancer: A Systematic Review and Meta-Analysis.
Int J Urol
Ji J, Guan F, Sun L, Zhang G.
PMID: 40631547 [PubMed - as supplied by publisher]
Unveiling the best immune checkpoint inhibitor-based therapy for metastatic renal cell carcinoma in the first-line setting: an updated systematic review and Bayesian network analysis.
Ther Adv Med Oncol
Wang J, Li X, Li M, Liu Q, Xie Z, Si X, Yang L, Wang Z, Ding D.
PMID: 40631349 [PubMed]
Cell-free DNA whole-genomes reveal chromosomal rearrangements associated with heterogeneity and stem cell-like castration-resistant prostate cancer.
medRxiv
Roskes ML, Martinez-Fundichely A, Cohen S, Balaban M, Wong CK, Li W, Gonzalez TA, Tehim AB, Xu H, ElNaggar S, Myers M, Bareja R, Dorsaint P, Gorski K, Asad M, Assaad MA, Robinson BD, Sigouros M, Barnett E, Manohar J, Tagawa S, Nanus D, Molina A, Nauseef JT, Sternberg CN, Mosquera JM, Scher HI, Sboner A, Raphael BJ, Chen Y, Khurana E.
PMID: 40630580 [PubMed]
Evaluating PI-RADS lesions and clinically significant prostate cancer in Black and Asian men: a PREVENT randomized clinical trial secondary analysis.
Res Sq
Driscoll C, Handa N, Huang M, Murphy A, Hu J, Schaeffer E.
PMID: 40630527 [PubMed]
Mechanistic study of CTHRC1 in promoting Wilms' tumor progression by regulating M2-type tumor-associated macrophages polarization.
J Transl Med
Zhuo Y, Feng X, Zhang W, Du J, Sun X, Luo X, Wang W, Jiang H, Gu H.
PMID: 40629408 [PubMed - indexed for MEDLINE]
Successful Treatment of Growing Renal Angiomyolipomas With Low-Dose Everolimus in a School-Aged Child With Tuberous Sclerosis Complex.
Nephrology (Carlton)
Senoo S, Kanda S, Takizawa K, Terashima H, Kajiho Y, Harita Y.
PMID: 40628370 [PubMed - indexed for MEDLINE]
A prospective study of bladder volume assessment using ultrasound in prostate cancer radiotherapy: Comparison with cone-beam computed tomography (CBCT).
Radiography (Lond)
B, Kaczmarek K, Rado, Winiecki T, Bajon T.
PMID: 40627993 [PubMed - as supplied by publisher]
Geographical Differences in the Management and Outcomes of Patients With Advanced Urothelial Carcinoma Treated With Pembrolizumab After Progression on Platinum-Based Chemotherapy: Results From ARON-2 Study.
JCO Glob Oncol
Rizzo M, Soares A, Gupta S, Calabrò F, Takeshita H, Bourlon MT, Park SH, Giannatempo P, Myint ZW, Büttner T, Grande E, Fiala O, Santini D, Bamias A, Zakopoulou R, Buti S, Kanesvaran R, Rescigno P, Molina-Cerrillo J, Epstein I, Marques Monteiro FS, Massari F, Porta C, Bellmunt J, Santoni M.
PMID: 40627820 [PubMed - indexed for MEDLINE]
Male Breast Cancer After Kidney Transplant: Case Report and Literature Revue.
Exp Clin Transplant
Chaker H, Yaich S, Abid H, Khemiri S, Charfi S, Masmoudi M, Ben Hmida M, Boudawara T, Khanfir A, Kammoun K.
PMID: 40626825 [PubMed - indexed for MEDLINE]
Invasiveness or growth pattern in urothelial tumours. A perspective to rethink the current WHO classification.
Pathologica
Lee J, Choi S, Kwon GY.
PMID: 40626668 [PubMed - indexed for MEDLINE]
A Comparison of Stockholm3, Serum Biomarkers, and Risk Calculators to Predict Prostate Cancer in a Racially and Ethnically Diverse Cohort: Evaluation of the Stockholm3 Multiethnic SEPTA Trial: Erratum.
J Urol
Lazarovich A, Vigneswaran H, Palsdottir T, Eklund M, Discacciati A, Nordström T, Hubbard RA, Perlis N, Abern MR, Moreira DM, Yonover P, Chow AK, Watts K, Liss MA, Thoreson GR, Abreu AL, Sonn GA, Plym A, Wiklund F, Grönberg H, Murphy AB, Eggener S.
PMID: 40626447 [PubMed]
Evaluation of the changes in hydrogel spacer volume in patients treated with proton therapy for prostate cancer.
BMC Urol
Inoue K, Shinohara M, Saka T, Hirao Y, Shinohara Y, Higashikawa T, Yamamoto M.
PMID: 40624549 [PubMed - indexed for MEDLINE]
Clinicopathologic and prognosis of 30 patients with FH-deficient renal cell carcinoma: a single-center retrospective study.
BMC Cancer
Bai J, Huang J, Ye Y, Lin J, Wen Y, Cai Z, Chen P, Shangguan T, Zou G, Qiu Q, Chen R, Liu R, Cai W, Zhu S, Chen J, Li X.
PMID: 40624460 [PubMed - indexed for MEDLINE]
Real-world trends in the use and outcomes of novel androgen receptor signaling inhibitor therapy in patients with non-metastatic castration-resistant prostate cancer: a multicenter retrospective study.
Int J Clin Oncol
Yoneyama F, Fujita N, Kawashima Y, Shinohara M, Tabata R, Tanaka R, Oishi T, Miura H, Togashi K, Okita K, Horiguchi H, Tanaka T, Noro D, Suzuki Y, Sato S, Ohyama C, Hatakeyama S.
PMID: 40624429 [PubMed - as supplied by publisher]
Holmium laser enucleation of the prostate and strictures: long-term outcomes, stricture characteristics, and risk factors.
World J Urol
Glienke M, Sigle A, Himmelsbach R, von Bargen MF, Schoenthaler M, Özkan A, Schoeb DS, Wilhelm K, Gratzke C, Miernik A.
PMID: 40624360 [PubMed - indexed for MEDLINE]
Rectal spacer use and bowel, urinary, and sexual dysfunction diagnosis and related procedures among men receiving prostate radiotherapy: US county-level analysis.
World J Urol
Yu JB, Folkert MR, Sato R, Collins S, Hankins R, Mehta P, Bhattacharyya S, Ezekekwu E, Hamstra DA.
PMID: 40624294 [PubMed - indexed for MEDLINE]
Development and retrospective validation of an artificial intelligence system for diagnostic assessment of prostate biopsies: study protocol.
BMJ Open
Mulliqi N, Blilie A, Ji X, Szolnoky K, Olsson H, Titus M, Martinez Gonzalez G, Boman SE, Valkonen M, Gudlaugsson E, Kjosavik SR, Asenjo J, Gambacorta M, Libretti P, Braun M, Kordek R, , Hotakainen K, Väre P, Pedersen BG, Sørensen KD, Ulhøi BP, Rantalainen M, Ruusuvuori P, Delahunt B, Samaratunga H, Tsuzuki T, Janssen EAM, Egevad L, Kartasalo K, Eklund M.
PMID: 40623883 [PubMed - indexed for MEDLINE]
Articles 1 - 20 / 177845
Page 1 of 8893
Rect Bottom
Anzeige
Adserver Footer
Time frame
--unlimited--
1 Week
1 Month
3 Months
6 Months
1 Year
2 Years
3 Years
5 Years
10 Years
Sky right 1
Anzeige
Mediscope AG E-mail:
info@mediscope.ch
Disclaimer
|
Privacy Policy